[
    [
        {
            "time": "2018-03-20",
            "original_text": "【天风Morning Call】晨会集萃20180320",
            "features": {
                "keywords": [
                    "晨会",
                    "集萃",
                    "天风"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【天风Morning Call】晨会集萃20180320",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 3,
                "Entity_Density": 2,
                "Market_Scope": 5,
                "Time_Proximity": 2,
                "Headline_Structure": 6,
                "Source_Recency": 2
            }
        },
        {
            "time": "2018-03-20",
            "original_text": "医药外包行业系列研究报告之二:CRO,创新药浪潮下的“力量倍增器”",
            "features": {
                "keywords": [
                    "CRO",
                    "创新药",
                    "医药外包"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药外包行业系列研究报告之二:CRO,创新药浪潮下的“力量倍增器”",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 4,
                "Headline_Structure": 8,
                "Source_Recency": 3
            }
        },
        {
            "time": "2018-03-20",
            "original_text": "医药行业中研发外包行业迎来高景气周期(系列二):基于12家CRO、CDMO企业的比较分析",
            "features": {
                "keywords": [
                    "CRO",
                    "CDMO",
                    "高景气周期",
                    "医药外包"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药行业中研发外包行业迎来高景气周期(系列二):基于12家CRO、CDMO企业的比较分析",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 8,
                "Market_Scope": 8,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        }
    ]
]